NantHealth

NantHealth® and NantOmics to Present Data on Tumor Mutation Burden (TMB) and PD-L1 Expression in SDH/FH Mutated Solid Tumors at the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting

Results to be presented during the cancer prevention, hereditary genetics and epidemiology session at the ASCO 2019 Annual Meeting CHICAGO, IL & CULVER CITY, CA – June 3, 2019 – NantWorks, LLC today announced that its affiliate companies, NantHealth, Inc.,...